Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays
- 11 March 1999
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 22 (3) , 203-208
- https://doi.org/10.1007/bf03343542
Abstract
Macroprolactinemia, i.e. sustained hyperprolactinemia where the predominant circulating form of prolactin (PRL) is of large molecular weight, is a common phenomenon comprising up to one-fourth of all cases of hyperprolactinemia. We measured serum PRL levels by four different immunoassay systems (PROL-CTK, RIAgnost, Delfia, ACS 180) and by the Nb2 bioassay in patients with prolactinomas/idiopathic hyperprolactinemias in whom monomeric PRL was the major species of PRL (n=11, group 1) and in patients with macroprolactinemia (n=12, group 2). In group 1, the results obtained with the different immunoassays and with the Nb2 assay were highly correlated (r=0.945−0.982). On the other hand, big big-PRL (bb-PRL) was differently recognized by the immunoassays, since measured serum PRL values from each patient were highly variable in group 2. RIA-gnost Prolactin and Delfia Prolactin detected bb-PRL similarly and they were highly correlated with each other (r=0.937, p<0.0001). ACS 180 detected bb-PRL somewhat differently from the RIA-gnost and Delfia systems, but likewise most of the patients of group 2 had PRL values above normal. PROL-CTK was the method less influenced by the presence of bb-PRL since most of the subjects with macroprolactinemia had PRL levels either within the normal range or only marginally elevated. From the immunoassays tested, PROL-CTK was the system which was less correlated with the Nb2 bioassay in group 2 (r=0.252; NS). Our experience is that macroprolactinemia is an asymptomatic condition in most of the cases. Therefore, we suggest that the routine measurement of PRL should be done with methods that are only minimally affected by the presence of macroprolactin. Such an approach would obviate the use of extensive, frequently expensive and ultimately useless diagnostic tests that are needed to determine the cause of the hyperprolactinemia.Keywords
This publication has 19 references indexed in Scilit:
- Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.Journal of Clinical Endocrinology & Metabolism, 1995
- Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL)Scandinavian Journal of Clinical and Laboratory Investigation, 1995
- Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complexExperimental and Clinical Endocrinology & Diabetes, 1995
- Detailed Assessment of Big Big Prolactin in Women with Hyperprolactinemia and Normal Ovarian FunctionJournal of Clinical Endocrinology & Metabolism, 1989
- Heterogeneity of Serum Prolactin Throughout the Menstrual Cycle and Pregnancy in Hyperprolactinemic Women with Normal Ovarian Function*Journal of Clinical Endocrinology & Metabolism, 1989
- Characterization of a Large Molecular Weight Prolactin in Women with Idiopathic Hyperprolactinemia and Normal Menses*Journal of Clinical Endocrinology & Metabolism, 1985
- Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinemia and spontaneous conceptionFertility and Sterility, 1982
- Heterogeneity of Pituitary and Plasma Prolactin in Man: Decreased Affinity of “Big” Prolactin in a Radioreceptor Assay and Evidence for Its Secretion*Journal of Clinical Endocrinology & Metabolism, 1978
- Size Heterogeneity of Human Prolactin in CSF and Serum: Experimental Conditions That Alter Gel Filtration Patterns*Journal of Clinical Endocrinology & Metabolism, 1978
- Heterogeneity of Human Growth Hormone and Prolactin Secretedin Vitro: Immunoassay and Radioreceptor Assay CorrelationsJournal of Clinical Endocrinology & Metabolism, 1975